[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2025 Transforming Growth Factor Beta 1 Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

March 2018 | 122 pages | ID: 253CDC2EB3BEN
QYResearch

US$ 3,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

This report studies the Transforming Growth Factor Beta 1 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Transforming Growth Factor Beta 1 market by product type and application/end industries.

The global Transforming Growth Factor Beta 1 market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Transforming Growth Factor Beta 1.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Transforming Growth Factor Beta 1 in these regions, from 2013 to 2025 (forecast), covering
  • United States
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa
The major players in global and United States market, including
  • Acceleron Pharma Inc
  • Eli Lilly and Co
  • Ensol Biosciences Inc
  • Formation Biologics Inc
  • Genzyme Corp
  • Huabo Biopharm Co Ltd
  • Isarna Therapeutics GmbH
  • Johnson & Johnson
  • Novartis AG
  • Scholar Rock Inc
  • Sirnaomics Inc
On the basis of product, the market is primarily split into
  • AVID-200
  • Decorin
  • Engedi-1000
  • Fresolimumab
  • Others
On the basis on the end users/application, this report covers
  • Osteoarthritis
  • Acute Pain
  • Autoimmune Disorders
  • Breast Cancer
  • Others
2018-2025 TRANSFORMING GROWTH FACTOR BETA 1 REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 TRANSFORMING GROWTH FACTOR BETA 1 MARKET OVERVIEW

2.1 Transforming Growth Factor Beta 1 Product Overview
2.2 Transforming Growth Factor Beta 1 Market Segment by Type
  2.2.1 AVID-200
  2.2.2 Decorin
  2.2.3 Engedi-1000
  2.2.4 Fresolimumab
  2.2.5 Others
2.3 Global Transforming Growth Factor Beta 1 Product Segment by Type
  2.3.1 Global Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Transforming Growth Factor Beta 1 Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Transforming Growth Factor Beta 1 Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Transforming Growth Factor Beta 1 Price (USD/Pcs) by Type (2013-2018)
2.4 United States Transforming Growth Factor Beta 1 Product Segment by Type
  2.4.1 United States Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Transforming Growth Factor Beta 1 Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States Transforming Growth Factor Beta 1 Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Transforming Growth Factor Beta 1 Price (USD/Pcs) by Type (2013-2018)

3 TRANSFORMING GROWTH FACTOR BETA 1 APPLICATION/END USERS

3.1 Transforming Growth Factor Beta 1 Segment by Application/End Users
  3.1.1 Osteoarthritis
  3.1.2 Acute Pain
  3.1.3 Autoimmune Disorders
  3.1.4 Breast Cancer
  3.1.5 Others
3.2 Global Transforming Growth Factor Beta 1 Product Segment by Application
  3.2.1 Global Transforming Growth Factor Beta 1 Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Transforming Growth Factor Beta 1 Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Transforming Growth Factor Beta 1 Product Segment by Application
  3.3.1 United States Transforming Growth Factor Beta 1 Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Transforming Growth Factor Beta 1 Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 TRANSFORMING GROWTH FACTOR BETA 1 MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Transforming Growth Factor Beta 1 Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Transforming Growth Factor Beta 1 Sales and Revenue by Regions
  4.2.1 Global Transforming Growth Factor Beta 1 Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Transforming Growth Factor Beta 1 Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL TRANSFORMING GROWTH FACTOR BETA 1 MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Transforming Growth Factor Beta 1 Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Transforming Growth Factor Beta 1 Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Transforming Growth Factor Beta 1 Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Transforming Growth Factor Beta 1 Manufacturing Base Distribution, Sales Area, Product Types
5.5 Transforming Growth Factor Beta 1 Market Competitive Situation and Trends
  5.5.1 Transforming Growth Factor Beta 1 Market Concentration Rate
  5.5.2 Global Transforming Growth Factor Beta 1 Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES TRANSFORMING GROWTH FACTOR BETA 1 MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Transforming Growth Factor Beta 1 Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Transforming Growth Factor Beta 1 Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Transforming Growth Factor Beta 1 Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Transforming Growth Factor Beta 1 Market Share (%) of Top 3 and Top 5 Players

7 TRANSFORMING GROWTH FACTOR BETA 1 PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Acceleron Pharma Inc
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Transforming Growth Factor Beta 1 Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Eli Lilly and Co
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Transforming Growth Factor Beta 1 Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Ensol Biosciences Inc
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Transforming Growth Factor Beta 1 Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Ensol Biosciences Inc Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Formation Biologics Inc
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Transforming Growth Factor Beta 1 Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Genzyme Corp
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Transforming Growth Factor Beta 1 Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 Huabo Biopharm Co Ltd
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Transforming Growth Factor Beta 1 Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Isarna Therapeutics GmbH
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Transforming Growth Factor Beta 1 Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Johnson & Johnson
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Transforming Growth Factor Beta 1 Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Johnson & Johnson Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Novartis AG
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Transforming Growth Factor Beta 1 Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Novartis AG Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Scholar Rock Inc
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Transforming Growth Factor Beta 1 Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Scholar Rock Inc Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Sirnaomics Inc

8 TRANSFORMING GROWTH FACTOR BETA 1 MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Transforming Growth Factor Beta 1 Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Transforming Growth Factor Beta 1 Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL TRANSFORMING GROWTH FACTOR BETA 1 MARKET FORECAST

10.1 Global Transforming Growth Factor Beta 1 Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.2 Global Transforming Growth Factor Beta 1 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Transforming Growth Factor Beta 1 Market Forecast
  10.2.1 United States Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Transforming Growth Factor Beta 1 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Transforming Growth Factor Beta 1 Forecast by Regions
  10.3.1 North America Transforming Growth Factor Beta 1 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Transforming Growth Factor Beta 1 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Transforming Growth Factor Beta 1 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Transforming Growth Factor Beta 1 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Transforming Growth Factor Beta 1 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Transforming Growth Factor Beta 1 Forecast by Type
  10.4.1 Global Transforming Growth Factor Beta 1 Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Transforming Growth Factor Beta 1 Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Transforming Growth Factor Beta 1 Forecast by Application
  10.5.1 Global Transforming Growth Factor Beta 1 Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States Transforming Growth Factor Beta 1 Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION



The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Transforming Growth Factor Beta 1 Product Picture
Figure Global Transforming Growth Factor Beta 1 Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Transforming Growth Factor Beta 1 Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of AVID-200
Table Major Players of AVID-200
Figure Global AVID-200 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Decorin
Table Major Players of Decorin
Figure Global Decorin Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Engedi-1000
Table Major Players of Engedi-1000
Figure Global Engedi-1000 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Fresolimumab
Table Major Players of Fresolimumab
Figure Global Fresolimumab Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Transforming Growth Factor Beta 1 Sales (K Pcs) by Type (2013-2018)
Table Global Transforming Growth Factor Beta 1 Sales Share (%) by Type (2013-2018)
Figure Global Transforming Growth Factor Beta 1 Sales Market Share (%) by Type (2013-2018)
Figure Global Transforming Growth Factor Beta 1 Sales Market Share (%) by Type in 2017
Table Global Transforming Growth Factor Beta 1 Revenue (Million USD) by Type (2013-2018)
Table Global Transforming Growth Factor Beta 1 Revenue Share (%) by Type (2013-2018)
Figure Global Transforming Growth Factor Beta 1 Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Transforming Growth Factor Beta 1 Revenue Market Share (%) by Type
Table Global Transforming Growth Factor Beta 1 Price (USD/Pcs) by Type (2013-2018)
Table United States Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Transforming Growth Factor Beta 1 Sales (K Pcs) by Type (2013-2018)
Table United States Transforming Growth Factor Beta 1 Sales Share (%) by Type (2013-2018)
Figure United States Transforming Growth Factor Beta 1 Sales Market Share (%) by Type (2013-2018)
Figure United States Transforming Growth Factor Beta 1 Sales Market Share (%) by Type in 2017
Table United States Transforming Growth Factor Beta 1 Revenue (Million USD) by Type (2013-2018)
Table United States Transforming Growth Factor Beta 1 Revenue Share (%) by Type (2013-2018)
Figure United States Transforming Growth Factor Beta 1 Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Transforming Growth Factor Beta 1 Revenue Market Share (%) by Type
Table United States Transforming Growth Factor Beta 1 Price (USD/Pcs) by Type (2013-2018)
Figure Osteoarthritis Examples
Figure Acute Pain Examples
Figure Autoimmune Disorders Examples
Figure Breast Cancer Examples
Figure Others Examples
Table Global Transforming Growth Factor Beta 1 Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Transforming Growth Factor Beta 1 Sales (K Pcs) by Application (2013-2018)
Table Global Transforming Growth Factor Beta 1 Sales Share (%) by Application (2013-2018)
Figure Global Transforming Growth Factor Beta 1 Sales Market Share (%) by Application (2013-2018)
Figure Global Transforming Growth Factor Beta 1 Sales Market Share (%) by Application in 2017
Table United States Transforming Growth Factor Beta 1 Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Transforming Growth Factor Beta 1 Sales (K Pcs) by Application (2013-2018)
Table United States Transforming Growth Factor Beta 1 Sales Share (%) by Application (2013-2018)
Figure United States Transforming Growth Factor Beta 1 Sales Market Share (%) by Application (2013-2018)
Figure United States Transforming Growth Factor Beta 1 Sales Market Share (%) by Application in 2017
Table Global Transforming Growth Factor Beta 1 Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Transforming Growth Factor Beta 1 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Transforming Growth Factor Beta 1 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Transforming Growth Factor Beta 1 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Transforming Growth Factor Beta 1 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Transforming Growth Factor Beta 1 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Transforming Growth Factor Beta 1 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Transforming Growth Factor Beta 1 Sales (K Pcs) by Regions (2013-2018)
Table Global Transforming Growth Factor Beta 1 Sales Market Share (%) by Regions (2013-2018)
Figure Global Transforming Growth Factor Beta 1 Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Transforming Growth Factor Beta 1 Sales Market Share (%) by Regions
Figure 2017 United States Transforming Growth Factor Beta 1 Sales Market Share (%) in Global Market
Table Global Transforming Growth Factor Beta 1 Revenue (Million USD) by Regions (2013-2018)
Table Global Transforming Growth Factor Beta 1 Revenue Market Share (%) by Regions (2013-2018)
Figure Global Transforming Growth Factor Beta 1 Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Transforming Growth Factor Beta 1 Revenue Market Share (%) by Regions
Figure 2017 United States Transforming Growth Factor Beta 1 Revenue Market Share (%) in Global Market
Table Global Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Transforming Growth Factor Beta 1 Sales (K Pcs) of Key Players (2013-2018)
Table Global Transforming Growth Factor Beta 1 Sales Share (%) by Players (2013-2018)
Figure 2017 Global Transforming Growth Factor Beta 1 Sales Share (%) by Players
Figure 2018 Global Transforming Growth Factor Beta 1 Sales Share (%) by Players
Table Global Transforming Growth Factor Beta 1 Revenue (Million USD) by Players (2013-2018)
Table Global Transforming Growth Factor Beta 1 Revenue Share (%) by Players (2013-2018)
Table 2017 Global Transforming Growth Factor Beta 1 Revenue Share (%) by Players
Table 2018 Global Transforming Growth Factor Beta 1 Revenue Share (%) by Players
Table Global Market Transforming Growth Factor Beta 1 Average Price (USD/Pcs) by Players (2013-2018)
Table Global Transforming Growth Factor Beta 1 Top Players Manufacturing Base Distribution and Sales Area
Table Global Transforming Growth Factor Beta 1 Top Players Product Category
Figure Global Transforming Growth Factor Beta 1 Market Share (%) of Top 3 Players
Figure Global Transforming Growth Factor Beta 1 Market Share (%) of Top 5 Players
Table United States Transforming Growth Factor Beta 1 Sales (K Pcs) by Players (2013-2018)
Table United States Transforming Growth Factor Beta 1 Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Transforming Growth Factor Beta 1 Sales Share (%) by Players
Figure 2018 United States Transforming Growth Factor Beta 1 Sales Share (%) by Players
Table United States Transforming Growth Factor Beta 1 Revenue (Million USD) by Players (2013-2018)
Table United States Transforming Growth Factor Beta 1 Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Transforming Growth Factor Beta 1 Revenue Share (%) by Players
Table 2018 United States Transforming Growth Factor Beta 1 Revenue Share (%) by Players
Table United States Market Transforming Growth Factor Beta 1 Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Transforming Growth Factor Beta 1 Market Share (%) of Top 3 Players
Figure United States Transforming Growth Factor Beta 1 Market Share (%) of Top 5 Players
Table Acceleron Pharma Inc Basic Information List
Table Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales Growth Rate (2013-2018)
Figure Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales Global Market Share (%)(2013-2018)
Figure Acceleron Pharma Inc Transforming Growth Factor Beta 1 Revenue Global Market Share (%)(2013-2018)
Table Eli Lilly and Co Basic Information List
Table Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Eli Lilly and Co Transforming Growth Factor Beta 1 Sales Growth Rate (2013-2018)
Figure Eli Lilly and Co Transforming Growth Factor Beta 1 Sales Global Market Share (%)(2013-2018)
Figure Eli Lilly and Co Transforming Growth Factor Beta 1 Revenue Global Market Share (%)(2013-2018)
Table Ensol Biosciences Inc Basic Information List
Table Ensol Biosciences Inc Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Ensol Biosciences Inc Transforming Growth Factor Beta 1 Sales Growth Rate (2013-2018)
Figure Ensol Biosciences Inc Transforming Growth Factor Beta 1 Sales Global Market Share (%)(2013-2018)
Figure Ensol Biosciences Inc Transforming Growth Factor Beta 1 Revenue Global Market Share (%)(2013-2018)
Table Formation Biologics Inc Basic Information List
Table Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Formation Biologics Inc Transforming Growth Factor Beta 1 Sales Growth Rate (2013-2018)
Figure Formation Biologics Inc Transforming Growth Factor Beta 1 Sales Global Market Share (%)(2013-2018)
Figure Formation Biologics Inc Transforming Growth Factor Beta 1 Revenue Global Market Share (%)(2013-2018)
Table Genzyme Corp Basic Information List
Table Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Genzyme Corp Transforming Growth Factor Beta 1 Sales Growth Rate (2013-2018)
Figure Genzyme Corp Transforming Growth Factor Beta 1 Sales Global Market Share (%)(2013-2018)
Figure Genzyme Corp Transforming Growth Factor Beta 1 Revenue Global Market Share (%)(2013-2018)
Table Huabo Biopharm Co Ltd Basic Information List
Table Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Sales Growth Rate (2013-2018)
Figure Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Sales Global Market Share (%)(2013-2018)
Figure Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Revenue Global Market Share (%)(2013-2018)
Table Isarna Therapeutics GmbH Basic Information List
Table Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales Growth Rate (2013-2018)
Figure Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales Global Market Share (%)(2013-2018)
Figure Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Revenue Global Market Share (%)(2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Johnson & Johnson Transforming Growth Factor Beta 1 Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Transforming Growth Factor Beta 1 Sales Global Market Share (%)(2013-2018)
Figure Johnson & Johnson Transforming Growth Factor Beta 1 Revenue Global Market Share (%)(2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Novartis AG Transforming Growth Factor Beta 1 Sales Growth Rate (2013-2018)
Figure Novartis AG Transforming Growth Factor Beta 1 Sales Global Market Share (%)(2013-2018)
Figure Novartis AG Transforming Growth Factor Beta 1 Revenue Global Market Share (%)(2013-2018)
Table Scholar Rock Inc Basic Information List
Table Scholar Rock Inc Transforming Growth Factor Beta 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Scholar Rock Inc Transforming Growth Factor Beta 1 Sales Growth Rate (2013-2018)
Figure Scholar Rock Inc Transforming Growth Factor Beta 1 Sales Global Market Share (%)(2013-2018)
Figure Scholar Rock Inc Transforming Growth Factor Beta 1 Revenue Global Market Share (%)(2013-2018)
Table Sirnaomics Inc Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transforming Growth Factor Beta
Figure Transforming Growth Factor Beta 1 Industrial Chain Analysis
Table Major Buyers of Transforming Growth Factor Beta
Table Distributors/Traders List
Figure Global Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Transforming Growth Factor Beta 1 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Transforming Growth Factor Beta 1Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Transforming Growth Factor Beta 1 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Transforming Growth Factor Beta 1 Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Transforming Growth Factor Beta 1 Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Transforming Growth Factor Beta 1 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Transforming Growth Factor Beta 1 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Transforming Growth Factor Beta 1 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Transforming Growth Factor Beta 1 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Transforming Growth Factor Beta 1 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Transforming Growth Factor Beta 1 Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Transforming Growth Factor Beta 1 Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Transforming Growth Factor Beta 1 Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Transforming Growth Factor Beta 1 Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Transforming Growth Factor Beta 1 Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Transforming Growth Factor Beta 1 Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Transforming Growth Factor Beta 1 Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Transforming Growth Factor Beta 1 Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Transforming Growth Factor Beta 1 Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Transforming Growth Factor Beta 1 Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2018-2025)
Table United States Transforming Growth Factor Beta 1 Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Transforming Growth Factor Beta 1 Sales Forecast by Application (2018-2025)


More Publications